LEAWOOD, Kan.----Madeira Therapeutics, a Kansas-based company specializing in pediatric pharmaceuticals, announced today that Peter Joiner, Madeira president and chief executive officer, will present an overview of the company at the 11th Annual C21 BioVentures Conference on April 9, 2009, at 10:15 am at the Meritage Resort in Napa, California.